TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer

Aberrant activation of beta-catenin/TCF (T-cell factor) signaling is frequently observed in the pancreatic cancer. However, the regulation of nuclear beta-catenin/TCF transcription machinery remains largely unknown. In this study, TFCP2 (transcriptional factor CP2) expression in pancreatic cancer wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuedi, Dai, Yuankun, Cai, Jiaying, Zhao, Han, Liu, Yueqi, Wang, Houbao, Liu, Dexiang, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642575/
https://www.ncbi.nlm.nih.gov/pubmed/29050300
http://dx.doi.org/10.18632/oncotarget.19741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642575/
https://www.ncbi.nlm.nih.gov/pubmed/29050300
http://dx.doi.org/10.18632/oncotarget.19741

Ejemplares similares